Johnson & Johnson 4.38% 2033/12
Sign up free to see prices on this bond
Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.
About this bond
AI BRIEF · GROUNDED IN STRUCTURED DATAJohnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.
Source: Wikipedia →Risk analytics
SEMI-ANNUAL · BULLET · PAR 100Price history
Sherpa Signal
AS OF 2026-04-30Institutional footprint · signal-level holdings
Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.
RFQ routing · coming soon
Security details
AWAITING ENRICHMENTIssuer curve
Johnson · 10 PTSYield (%) plotted against years-to-maturity. This bond highlighted in amber.
Bonds like this
HEURISTICSame currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.